Affordable Access

Publisher Website

Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case report.

Authors
Type
Published Article
Journal
Tumori Journal
0300-8916
Publisher
"Wichtig Publishing, SRL"
Publication Date
Volume
99
Issue
5
Identifiers
DOI: 10.1700/1377.15325
PMID: 24362879
Source
Medline

Abstract

Nuclear localization of CD133 may be an indicator of poor prognosis in TN breast cancer, as it is known that surface molecules, when moving into the nucleus, can act as transcriptional regulators by interfering with molecular pathways directly connected to the proliferation and differentiation of tumor cells.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments